Akoya Biosciences Inc (AKYA) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Akoya Biosciences Inc   (NASDAQ: AKYA)


Akoya Biosciences Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Akoya Biosciences Inc's ROI in the first quarter of 2025?
Akoya Biosciences Inc recorded a cumulative net loss of $-48 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -60.72%.

Within the Healthcare sector 468 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2025 quarter, so far to 2827, from total ROI ranking in the fourth quarter of 2024 at 2966.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -43.03 % -21.67 % -15.17 % -8.49 % -1.03 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 96 102 111 122
Return On Investment (TTM) -60.72 % -51.49 % -49.4 % -47.42 % -49.5 %
AKYA's Overall Ranking # 2827 # 2966 # 3048 # 3095 # 2728
Seq. Investment Change TTM -27.2 % -8.36 % -7.81 % -7.37 % 0.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -48 -55 -58 -60 -68

AKYA Company Profile >> Back to AKYA Roi Comparisons >> See Annual AKYA Return On Investment



Return On Investment AKYA's Ranking
Within: No.
Industry # 12
Sector # 469
Overall # 2827

Return On Investment Statistics
High Average Low
-29.35 %
-48.53 %
-60.13 %
(Dec 31 2021)   (Mar 31 2025)







Financial Statements
Akoya Biosciences Inc's I. Quarter Investments $ 5 Millions AKYA's Balance sheet
Akoya Biosciences Inc's I. Quarter Income $ -16 Millions Quarterly AKYA's Income Statement
AKYA's Income by Division See AKYA's Income by Division


AKYA Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 96 135 139 163 0
Y / Y Investment Growth -29.11 % -3 % -14.86 % - -
Net Income in Millions -55 -63 -71 -43 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -57.94 % -46.98 % -50.83 % -26.3 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AKYA's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AKYA's Competitors
Subscribers only: Roi for Akoya Biosciences Inc's Suppliers
Subscribers only: Return On Investment for AKYA's Customers

Other Ratios
AKYA's Roa AKYA's Inventory Turnover Ratio AKYA's Growth Rates AKYA's Dividend Statistics
AKYA's Profitability Ratios AKYA's Asset Turnover Ratio AKYA's Dividend Growth
AKYA's Roe AKYA's Valuation Ratios AKYA's Financial Strength Ratios AKYA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.